Marijuana Moment
The Nevada Assembly has amended and advanced a Senate-passed joint resolution calling on Congress to reschedule certain psychedelics, streamline research and provide protections for people using the substances in compliance with state law.
On the chamber floor on Thursday, lawmakers voted 36-6 to advance the measure—SJR 10, from Sen. Rochelle Nguyen (D)—which now returns to the Senate to consider changes made in the Assembly.
The resolution cites research demonstrating the therapeutic potential of psychedelics in the treatment of serious mental health conditions and calls on the federal government to “reschedule psilocybin, psilocin, DMT, ibogaine, mescaline and MDMA to a schedule that better reflects the therapeutic value, low potential for abuse and safety for use under medical supervision of those compounds.”
